GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pasithea Therapeutics Corp (NAS:KTTAW) » Definitions » Total Liabilities

Pasithea Therapeutics (Pasithea Therapeutics) Total Liabilities : $2.53 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Pasithea Therapeutics Total Liabilities?

Pasithea Therapeutics's Total Liabilities for the quarter that ended in Mar. 2024 was $2.53 Mil.

Pasithea Therapeutics's quarterly Total Liabilities increased from Sep. 2023 ($2.28 Mil) to Dec. 2023 ($2.72 Mil) but then declined from Dec. 2023 ($2.72 Mil) to Mar. 2024 ($2.53 Mil).

Pasithea Therapeutics's annual Total Liabilities increased from Dec. 2021 ($1.90 Mil) to Dec. 2022 ($2.68 Mil) and increased from Dec. 2022 ($2.68 Mil) to Dec. 2023 ($2.72 Mil).


Pasithea Therapeutics Total Liabilities Historical Data

The historical data trend for Pasithea Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pasithea Therapeutics Total Liabilities Chart

Pasithea Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Liabilities
0.01 1.90 2.68 2.72

Pasithea Therapeutics Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.91 2.56 2.28 2.72 2.53

Pasithea Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Pasithea Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.634+(0+0.084
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=2.72

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=26.117-23.398
=2.72

Pasithea Therapeutics's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.467+(0+0.058
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=2.53

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=22.408-19.883
=2.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pasithea Therapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Pasithea Therapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Pasithea Therapeutics (Pasithea Therapeutics) Business Description

Traded in Other Exchanges
Address
1111 Lincoln Road, Suite 500, Miami Beach, FL, USA, 33139
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.